第4代达芬奇机器人手术系统辅助六孔法直肠癌前切除术的临床疗效

Clinical efficacy of da Vinci Xi surgical system assisted programmed six‑hole method anterior resection of rectal cancer

  • 摘要:
    目的 探讨第4代达芬奇机器人手术系统辅助六孔法直肠癌前切除术的临床疗效。
    方法 采用回顾性队列研究方法。收集2020年8月至2021年6月徐州医科大学附属医院收治的102例中低位直肠癌患者的临床病理资料;男62例,女40例;年龄为(53±12)岁。102例患者中,51例行第4代达芬奇机器人手术系统辅助六孔法直肠癌前切除术,设为机器人组;51例行腹腔镜直肠癌前切除术,设为腹腔镜组。观察指标:(1)治疗情况。(2)术后病理学检查结果。(3)随访情况。正态分布的计量资料以x±s表示,组间比较采用独立样本t检验;偏态分布的计量资料以M(范围)表示,组间比较采用Mann‑Whitney U检验。计数资料以绝对数表示,组间比较采用χ²检验或Fisher确切概率法。重复测量数据采用重复测量方差分析。
    结果 (1)治疗情况。两组患者均顺利施行直肠癌根治术,术中均无输血、中转开腹手术、术后30 d内死亡。机器人组患者手术时间,术中出血量,淋巴结清扫数目,术后首次肛门排气时间,术后首次进食流质食物时间,术后导尿管拔除时间,术后疼痛分级(1级、2级、3级、4级),治疗费用分别为(170±12)min,(73±50)mL,(23±6)枚,(35.1±9.4)h,(2.1±0.8)d,(2.9±2.7)d,13、15、17、6例,(7.1±4.5)万元;腹腔镜组上述指标分别为(153±22)min,(119±66)mL,(15±4)枚,(40.7±1.9)h,(2.9±0.4)d,(5.3±2.1)d,6、7、26、12例,(6.7±1.6)万元;两组患者上述指标比较,差异均有统计学意义(t=6.79、-4.46、20.09、-3.01、-5.54、-16.69,Z=-2.87,t=4.22,P<0.05)。(2)术后病理学检查结果。机器人组患者肿瘤长径,标本切除长度,肿瘤上切缘距离,肿瘤下切缘距离,全直肠系膜切除完整性分级(完整、大部分完整),肿瘤分化程度(高分化、中分化、低分化),术后TNM分期(Ⅰ期、Ⅱ期、Ⅲ期)分别为(3.8±1.1)cm,(18.7±3.2)cm,(11.8±3.6)cm,(2.7±0.8)cm,48、3例,4、41、6例,6、17、28例;腹腔镜组患者上述指标分别为(3.7±1.0)cm,(18.3±2.8)cm,(10.2±2.7)cm,(2.5±0.6)cm,46、5例,6、39、6例,5、20、26例;两组患者上述指标比较,差异均无统计学意义(t=1.72、1.29、1.64、1.11,χ²=0.14,Z=-0.42,-0.26,P>0.05)。机器人组患者无环周切缘阳性和肠系膜破坏,腹腔镜组患者上述指标均为1例,两组患者上述指标比较,差异均无统计学意义(P>0.05)。(3)随访情况。两组患者均获得术后12个月随访。两组患者术后均无肿瘤局部复发和远处转移。机器人组患者大便失禁严重程度评分、低前切除综合征评分、国际前列腺功能评分、夜间排尿评分、国际勃起功能指数问卷评分、女性性功能指数评分分别由术前的0、(12.25±1.08)分、(4.43±0.33)分、(0.49±0.09)分、(24.07±2.75)分、(65.84±1.79)分,变化为术后12个月的(1.34±0.11)分、(18.11±3.54)分、(4.03±0.26)分、(1.08±0.28)分、(22.63±2.03)分、(38.57±6.13)分;腹腔镜组上述指标分别由术前0、(12.60±1.11)分、(4.56±0.36)分、(0.46±0.07)分、(23.11±2.77)分、(66.31±1.73)分,变化为术后12个月的(1.99±1.33)分、(20.85±6.19)分、(6.43±1.78)分、(2.27±0.23)分、(21.00±2.73)分、(27.62±8.20)分;两组患者上述指标比较,差异均有统计学意义(P<0.05)。
    结论 第4代达芬奇机器人手术系统辅助六孔法直肠癌前切除术和腹腔镜直肠癌前切除术的肿瘤学疗效相当;但前者在术中出血量、淋巴结清扫、胃肠功能恢复和盆腔自主神经保护方面更优。

     

    Abstract:
    Objective To investigate the clinical efficacy of da Vinci Xi surgical system assisted programmed six‑hole method anterior resection of rectal cancer.
    Methods The retrospec-tive cohort study was conducted. The clinicopathological data of 102 patients with middle and low rectal cancer who were admitted to the Affiliated Hospital of Xuzhou Medical University from August 2020 to June 2021 were collected. There were 62 males and 40 females, aged (53±12)years. Of the 102 patients, 51 cases undergoing da Vinci Xi surgical system assisted programmed six-hole method anterior resection of rectal cancer were divided into the robotic group and 51 cases undergoing laparoscopic anterior resection of rectal cancer were divided into the laparoscopic group. Observa-tion indicators: (1) treatment; (2) postoperative pathological examination; (3) follow‑up. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was conducted using the independent sample t test. Measurement data with skewed distribution were represented as M(range), and comparison between groups was conducted using the Mann‑Whitney U test. Count data were described as absolute numbers, and comparison between groups was conducted using the chi‑square test or Fisher exact probability. Repeated measurement data were analyzed using the repeated ANOVA.
    Results (1) Treatment. All patients of the two groups under-went radical resection of rectal cancer successfully, and none of patient with intraoperative blood transfusion, conversion to open surgery, and death within 30 days after surgery. The operation time, volume of intraoperative blood loss, number of lymph nodes dissected, time to postoperative first flatus, time to postoperative first liquid food intake, time to postoperative catheter removal, cases with postoperative pain grading as grade 1, grade 2, grade 3, grade 4, cost of treatment were (170±12)minutes, (73±50)mL, 23±6, (35.1±9.4)hours, (2.1±0.8)days, (2.9±2.7)days, 13, 15, 17, 6, (7.1±4.5) ten thousand yuan in patients of the robotic group, versus (153±22)minutes, (119±66) mL, 15±4, (40.7±1.9)hours, (2.9±0.4)days, (5.3±2.1)days, 6, 7, 26, 12, (6.7±1.6) ten thousand yuan in patients of the laparoscopic group, showing significant differences in the above indicators between the two groups (t=6.79, -4.46,20.09, -3.01, -5.54, -16.69, Z=-2.87, t=4.22, P<0.05). (2) Postoperative patho-logical examination. The tumor diameter, length of specimen resected, distance of upper resection margin to tumor, distance of lower resection margin to tumor, cases with mesorectal specimens as integrity and mostly integrity, cases with tumor differentiation as high differentiation, moderate differentiation, low differentiation, cases with postoperative TNM staging as stage Ⅰ, stage Ⅱ, stage Ⅲ were (3.8±1.1)cm, (18.7±3.2)cm, (11.8±3.6)cm, (2.7±0.8)cm, 48, 3, 4, 41, 6, 6, 17, 28 in patients of the robotic group, versus (3.7±1.0)cm, (18.3±2.8)cm, (10.2±2.7)cm, (2.5±0.6)cm, 46, 5, 6, 39, 6, 5,20, 26 in patients of the laparoscopic group, showing no significant difference in the above indicators between the two groups (t=1.72, 1.29, 1.64, 1.11, χ²=0.14, Z=-0.42, -0.26, P>0.05). Cases with positive circumferential margin and cases with destruction of mesentery was 0 and 0 in patients of the robotic group, versus 1 and 1 in patients of the laparoscopic group, showing no significant difference in the above indicators between the two groups (P>0.05). (3) Follow‑up. All patients in the two groups were followed up for 12 months after surgery and none of patient had postoperative local recurrence and distant metastasis of tumors. The anal incontinence score, low anterior resection syndrome score, international prostate symptom score, night urination score, international index of erectile score, female sexual function index score in patients of the robotic group were 0, 12.25±1.08, 4.43±0.33, 0.49±0.09, 24.07±2.75, 65.84±1.79 before surgery and 1.34±0.11, 18.11±3.54, 4.03±0.26, 1.08±0.28, 22.63±2.03, 38.57±6.13 at postoperative 12 months, respectively. The above indicators in patients of the laparoscopic group were 0, 12.60±1.11, 4.56±0.36, 0.46±0.07, 23.11±2.77, 66.31±1.73 before surgery and 1.99±1.33,20.85±6.19, 6.43±1.78, 2.27±0.23, 21.00±2.73, 27.62±8.20 at postoperative 12 months, respectively. There were significant differences in the above indicators between the two groups (P<0.05).
    Conclusions The oncological effects of da Vinci Xi surgical system assisted programmed six‑hole method anterior resection of rectal cancer and lapa-roscopic anterior resection of rectal cancer are comparable. However, robotic surgery is superior to laparoscopic surgery in terms of intraoperative bleeding, lymph node dissection, gastrointestinal function recovery, and pelvic autonomic nerve protection.

     

/

返回文章
返回